Asset Acquisition, Maximum Aggregate Milestone Payments

No definition available.

Name:	cbio_AssetAcquisitionMaximumAggregateMilestonePayments
Namespace Prefix:	cbio_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Asset Acquisition, Maximum Aggregate, Milestone Payments 1

+ References

No definition available.

+ Details

Name:	cbio_AssetAcquisitionMaximumAggregateMilestonePayments1
Namespace Prefix:	cbio_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Asset Acquisition, Number Of Employees Overseeing And Coordinating Research Project

+ References

No definition available.

+ Details

Name:	cbio_AssetAcquisitionNumberOfEmployeesOverseeingAndCoordinatingResearchProject
Namespace Prefix:	cbio_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Asset Acquisition, Number Of Votes, Option Agreement

+ References

No definition available.

+ Details

Name:	cbio_AssetAcquisitionNumberOfVotesOptionAgreement
Namespace Prefix:	cbio_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Asset Acquisition, Option Agreement Expiration Period

+ References

No definition available.

+ Details

Name:	cbio_AssetAcquisitionOptionAgreementExpirationPeriod
Namespace Prefix:	cbio_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Asset Acquisition, Option Agreement Sublicense Agreement Period

+ References

No definition available.

+ Details

Name:	cbio_AssetAcquisitionOptionAgreementSublicenseAgreementPeriod
Namespace Prefix:	cbio_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Asset Acquisition, Option Agreement Termination Period

+ References

No definition available.

+ Details

Name:	cbio_AssetAcquisitionOptionAgreementTerminationPeriod
Namespace Prefix:	cbio_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Asset Acquisition, Option Agreement Termination Period, Breach Of Contract

+ References

No definition available.

+ Details

Name:	cbio_AssetAcquisitionOptionAgreementTerminationPeriodBreachOfContract
Namespace Prefix:	cbio_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Asset Acquisition, Option Agreement Termination Period, Maximum Contractual Period

+ References

No definition available.

+ Details

Name:	cbio_AssetAcquisitionOptionAgreementTerminationPeriodMaximumContractualPeriod
Namespace Prefix:	cbio_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Asset Acquisition, Royalty Percent Paid, Reduction Due To Invalid Patent

+ References

No definition available.

+ Details

Name:	cbio_AssetAcquisitionRoyaltyPercentPaidReductionDueToInvalidPatent
Namespace Prefix:	cbio_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Class Of Warrants Or Rights, Percent Of Outstanding Shares

+ References

No definition available.

+ Details

Name:	cbio_ClassOfWarrantsOrRightsPercentOfOutstandingShares
Namespace Prefix:	cbio_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.

+ References

No definition available.

+ Details

Name:	us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-4

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 805
-SubTopic 50
-Name Accounting Standards Codification
-Section 15
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480123/805-50-15-3

+ Details

Name:	us-gaap_AssetAcquisitionLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=us-gaap_LicenseAgreementTermsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	cbio_LicenseAgreementAxis=cbio_ParagonOptionAgreementsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=cbio_ParagonTherapeuticsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_StatementScenarioAxis=srt_ScenarioForecastMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=cbio_CR001Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=cbio_CR002Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=cbio_CR003Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Paragon Option Agreements - Narrative (Details) - Paragon Option Agreements $ in Millions				6 Months Ended	12 Months Ended
	Sep. 26, 2025 USD ($)	Apr. 28, 2025 USD ($)	Mar. 18, 2025 USD ($)	Sep. 30, 2025 USD ($) employee vote	Dec. 31, 2026	Dec. 31, 2025
License Agreement Terms
Asset Acquisition [Line Items]
Number of employees overseeing and coordinating the project \| employee				2
Paragon Therapeutics
Asset Acquisition [Line Items]
Accounts payable and other current liabilities				$ 6.3
Paragon Therapeutics \| Forecast
Asset Acquisition [Line Items]
Percent of outstanding shares					1.00%	1.00%
Paragon Therapeutics \| License Agreement Terms
Asset Acquisition [Line Items]
Number of employees overseeing and coordinating the project \| employee				2
Number of votes \| vote				1
Option agreement termination period, maximum contractual period				30 days
Expiration period				30 days
Termination period				30 days
Paragon Therapeutics \| License Agreement Terms \| CR-001
Asset Acquisition [Line Items]
Non-refundable milestone payments			$ 22.0
Milestone payment		$ 2.5
Percent reduction to royalty payment due to invalid patent				30.00%
Termination period due to breach of contract				60 days
Sublicense agreement period				30 days
Paragon Therapeutics \| License Agreement Terms \| CR-002
Asset Acquisition [Line Items]
Non-refundable milestone payments	$ 46.0
Paragon Therapeutics \| License Agreement Terms \| CR-003
Asset Acquisition [Line Items]
Non-refundable milestone payments		$ 46.0